pentobarbital will minimize the level or impact of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Use of alternative treatment options is strongly recommended when linagliptin is to be administered with a CYP3A4 inducerpentobarbital will decrease the extent or outcome of elbasvir/grazoprevir by impacting